Journal
CHEST
Volume 159, Issue 3, Pages E131-E135Publisher
ELSEVIER
DOI: 10.1016/j.chest.2020.10.003
Keywords
emphysema; filamin A; mutation
Categories
Ask authors/readers for more resources
Emphysema is a chronic respiratory disorder characterized by destruction of alveoli, usually caused by smoking or exposure to noxious particles or gases. Dysfunctions in proteins related to lung development and maintenance can also contribute to emphysema. Identifying new risk factors for emphysema can lead to screening, prevention, and monitoring efforts, as well as genetic testing in early-onset emphysema cases.
Emphysema is a chronic respiratory disorder characterized by destruction of alveoli, usually due to cigarette smoking or exposure to noxious particles or gases. Dysfunction of proteins that are involved in lung development and maintenance, such as alpha-1 antitrypsin, also contributes to emphysema. Filamin A (FLNA) is an actin-binding protein involved in cytoskeleton reorganization. Mutations in the FLNA gene classically lead to abnormal neuronal migration and connective and vascular tissue anomalies. Pulmonary manifestations consist of a wide range of pulmonary disorders that occur during infancy. We report the first familial case of emphysema in non- and very low-smoking adults who carry a loss-of-function mutation of the FLNA gene. The identification of this new risk factor for emphysema encourages (1) screening, prevention and monitoring of pulmonary disorders in patients with FLNA mutation and (2) screening for FLNA mutation in patients with early-onset emphysema that is associated with low-smoking or vascular or connective tissue anomalies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available